Replay available

CohBar, Inc. (CWBR) Q1 2022 Earnings Call

CohBar, Inc. (NASDAQ: CWBR) Q1 2022 earnings conference call, held 2022-05-16. Replay captured from the company's public earnings webcast.

Mon, May 16, 2022 at 5:00 PMendedReplay
CohBar, Inc. (CWBR) Q1 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jeff Beuno

Chief Financial Officer

Joe Surrett

Chief Executive Officer

Kent Grindstaff

Senior Vice President of Research

Nick Vlahakis

Acting Chief Medical Officer

Kumar Raja

Analyst at Brookline Capital Markets

Replay transcript excerpt

Good afternoon. My name is John, and I will be your conference operator today. At this time, I would like to welcome everyone to COBAR's first quarter 2022 financial results conference call. All lines have been placed on mute to eliminate background noise. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. And now I would like to turn the call over to Jeff Beuno, Chief Financial Officer at COBAR. Thank you, sir. Thank you, John, and thank you, everyone, for joining COBAR's first quarter 2022 financial results conference call. Joining me on today's call is Dr. Joe Surrett, COBAR's chief executive officer, Dr. Nick Vlahakis, COBAR's acting chief medical officer, and Dr. Kent Grindstaff, senior vice president of research. Following our collective remarks, we will conclude with Q&A. COBAR's financial results press release was issued earlier today and may be downloaded from our website at www.cobar.com. Before we begin, I'd like to take a moment to remind listeners that except for statements of historical fact, remarks on today's conference call may include forward-looking statements within the meaning of the securities laws. Forward-looking statements are based on current expectations, projections, and interpretations that involve a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by COBAR. These risks and uncertainties are described in our registration statements, reports, and other filings with the Securities and Exchange Commission and applicable Canadian securities regulators, which are available on our website at cobar.com, sec.gov, and cdar.com, as well as in the Safe Harbor Statement included with today's press release. You are cautioned t...

More from Tuhura Biosciences, Inc.